Life sciences companies have an opportunity to build markets and categories for new medicines and medical products that promise better efficacy, safety, value and price. As these companies reach the proof-of-concept stage with their technologies, it is wise to begin shaping markets in advance of regulatory approval, often enhancing company value as a result.
This program will help innovators expand their thinking beyond the next fund raise and build longer-term value for stakeholders. Listen to two case studies of companies that invested in advance of product marketing, clearance and launch. Q&A time included.
What you will learn:
At what company stage to begin thinking about market shaping
Strategies and tactics to lay the foundation for shifting perceptions ahead of pre-commercial launch
Which stakeholders to involve in market shaping
How to measure the impact of market shaping activities